Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study
about
The Crossroads of Geriatric Cardiology and Cardio-OncologyCardiac effects of anticancer therapy in the elderlyAcute coronary syndrome induced by oral capecitabine.Cardiotoxicity of cancer therapy.A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity.Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis.Clinical pharmacology of chemotherapy agents in older people with cancerElectrocardiographic and cardiovascular effects of the 5-hydroxytryptamine3 receptor antagonists.Cardiotoxicity of commercial 5-fluorouracil vials stems from the alkaline hydrolysis of this drug.A case of severe coronary spasm associated with 5-fluorouracil chemotherapy.Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity.Mechanisms of Cardiotoxicity of Cancer Chemotherapeutic Agents: Cardiomyopathy and Beyond.Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer.Timely recognition of cardiovascular toxicity by anticancer agents: a common objective of the pharmacologist, oncologist and cardiologist.5-FU-induced cardiac toxicity--an underestimated problem in radiooncology?Myocardial infarction caused by pharmacological substances - case description and literature reviewParadoxical effect of capecitabine in 5-fluorouracil-induced cardiotoxicity: A case vignette and literature review.Arrhythmias and Other Electrophysiology Issues in Cancer Patients Receiving Chemotherapy or Radiation.Fluoropyrimidine-Induced Cardiotoxicity: Manifestations, Mechanisms, and Management.Fluorouracil cardiotoxicity.The anti-cancer drug 5-fluorouracil is metabolized by the isolated perfused rat liver and in rats into highly toxic fluoroacetate.5-fluorouracil induced pericarditis.Rituximab-induced coronary vasospasm.Clinical cardiotoxicity of 5-fluorouracil.Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina.A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma.Capecitabine-induced coronary vasospasm--a case report.Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1.Coronary artery spasm induced by 5-fluorouracil.A comparison of cardiomyocyte cytotoxic mechanisms for 5-fluorouracil and its pro-drug capecitabine.Fluoropyrimidine-induced cardiac toxicity: challenging the current paradigm.Long-Term and Latent Side Effects of Specific Cancer Types.5-fluorouracil and cardiotoxicity: a review.Effects of granisetron with doxorubicin or epirubicin on ECG intervalsIs 5-fluorouracil-induced vasospasm a Kounis syndrome? A diagnostic challenge
P2860
Q26778666-AB129FF1-5666-4D40-B7BC-12DD7579F6F0Q26863244-115FE06C-A142-4963-82B6-AC783B2BAC72Q33235644-94A4FBB4-50FD-4DA4-8AD9-195C6DA8437CQ33704056-A874C863-856C-4D42-A9D3-16C8EDA8D9E3Q34219095-209AD13A-F721-48F7-9983-87234EFFFF5AQ34659375-756A521C-4524-4721-A6E9-96BAC05CD4B4Q35159253-8AE38DCC-B9E0-432B-9F29-598954D133DDQ35201044-69D6E62C-4198-44E4-B479-4AE502F8FF23Q35994362-7446DD62-E538-480A-B9B4-EA38AF94F554Q36237986-D690D0AD-A4DD-463E-88FD-B310744319DAQ36292188-54D11861-B91F-45C2-81E2-F221774CB3FBQ37038711-AE9A0003-2E5A-45CB-ACE8-C44324FA8FDAQ37355866-B7C50019-0DDB-431A-92DA-3F961ABF37CDQ37926954-A87DB02A-1BEC-40A6-8E8E-B5CC0866AB86Q38067509-962FD247-2AD9-4427-9CA7-81BF67B2B7CAQ38191218-9A41311D-BCDF-42C1-8B4D-901E17D0D8A1Q38410725-FE5A68A1-5FAB-4A97-8457-80C83CD6CFFAQ38815946-1AF800F0-267C-43F5-8B77-C3E56A24A6A4Q38817372-636C67E6-103B-48BC-992E-C883DAC00C7CQ40757488-66024D0D-B7F0-4336-BF21-F8340E2A8D86Q41877476-D2886609-E061-4E94-88C3-A21F33DCBF7BQ41963581-B9C3B086-E715-44BA-97CA-EFB15427A780Q42278780-B5BCEDE3-E92C-44FC-8240-CAF4A9562272Q42287513-AD2A5B2F-DA60-4996-9269-0A4162452BB3Q43042597-5EF8C830-5D31-4571-BD69-976DBCC97E6DQ44168582-15A6F5F6-B878-4A95-83A0-A4973C17DE8BQ44753305-B7EE86DF-F689-4814-B11F-D11C9A6E0D4AQ45073135-53658B1A-498E-4E26-BF48-B1460122B87EQ45237039-DADC348F-0CBC-4414-976E-9F31F38BD2DBQ46865578-95C375C8-D3A9-45ED-B587-1DFCEC5E8EEEQ47177827-C3E08BBF-07B7-4018-A37E-DFE970160419Q47602301-2F701D76-F896-43EA-AAB7-5C26F2B6FC9AQ55515022-F2FCBE50-0FBE-469B-8685-7E5F0CE49BB3Q57278979-D25074FE-B3BE-472E-8E7E-23E23914DAC3Q58033437-6D91E5BE-3EDA-40FC-9D13-CDB5F1F227CB
P2860
Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study
description
1989 nî lūn-bûn
@nan
1989 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study
@ast
Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study
@en
Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study
@nl
type
label
Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study
@ast
Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study
@en
Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study
@nl
prefLabel
Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study
@ast
Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study
@en
Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study
@nl
P2093
P3181
P356
P1476
Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study
@en
P2093
A Olivenstein
M al-Sarraf
R A Kloner
S Kerpel-Fronious
S Rezkalla
P304
P3181
P356
10.1200/JCO.1989.7.4.509
P407
P577
1989-04-01T00:00:00Z